Bafna Pharmaceuticals Limited
₹80
INR+0.95(+1.20%)
As of November 14, 2024 10:00:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹191.62 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹212.04 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
675.00
Forward P/E
Price to Earnings ratio based on forecasted earnings
NA
PEG Ratio
Price/Earnings to Growth ratio
NA
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
1.33
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
24.60%
Operating Margin
Operating income as a percentage of revenue
-0.70%
Return on Equity
Net income as a percentage of shareholders' equity
9.09%
Revenue (TTM)
Total revenue over trailing 12 months
₹143.80 Cr-20.599999999999998%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹14.63 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹0.120
Balance Sheet
Total Cash
Total cash and short-term investments
₹1.40 Cr
Total Debt
Total short-term and long-term debt
₹24.39 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
30.17%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹73.25 - ₹113
Beta
Measure of stock's volatility compared to the market
0.42
Shares Outstanding
Total number of shares issued by the company
₹2.37 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
3.05%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.00%
Payout Ratio
Percentage of earnings paid as dividends
0.00%